DK103780C - Fremgangsmåde til fremstilling af lumilysergolderivater. - Google Patents

Fremgangsmåde til fremstilling af lumilysergolderivater.

Info

Publication number
DK103780C
DK103780C DK270863AA DK270863A DK103780C DK 103780 C DK103780 C DK 103780C DK 270863A A DK270863A A DK 270863AA DK 270863 A DK270863 A DK 270863A DK 103780 C DK103780 C DK 103780C
Authority
DK
Denmark
Prior art keywords
lumilyser
preparation
gold derivatives
gold
derivatives
Prior art date
Application number
DK270863AA
Other languages
Danish (da)
English (en)
Original Assignee
Farmaceutici Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia filed Critical Farmaceutici Italia
Application granted granted Critical
Publication of DK103780C publication Critical patent/DK103780C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK270863AA 1962-06-11 1963-06-07 Fremgangsmåde til fremstilling af lumilysergolderivater. DK103780C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1167062 1962-06-11

Publications (1)

Publication Number Publication Date
DK103780C true DK103780C (da) 1966-02-21

Family

ID=11136772

Family Applications (1)

Application Number Title Priority Date Filing Date
DK270863AA DK103780C (da) 1962-06-11 1963-06-07 Fremgangsmåde til fremstilling af lumilysergolderivater.

Country Status (8)

Country Link
US (1) US3228943A (de)
AT (1) AT258481B (de)
BR (1) BR6349779D0 (de)
CH (1) CH446367A (de)
DK (1) DK103780C (de)
ES (1) ES288887A1 (de)
GB (1) GB981827A (de)
SE (1) SE315904B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879554A (en) * 1970-03-20 1975-04-22 Farmaceutici Italia Use of 1,6-dimethyl-8-{62 -(5-bromonicotinoyloxymethyl)-10 {60 -methoxyergoline in treating cerebral and peripheral metabolic vascular disorders
NL159384B (nl) * 1971-03-13 1979-02-15 Farmaceutici Italia Werkwijze voor het bereiden van een geneesmiddel met een adrenolytische activiteit, alsmede werkwijze voor het bereiden van een ester van 1-methyl-10-methoxylumilysergol.
GB1413068A (en) * 1972-06-22 1975-11-05 Farmaceutici Italia Bromoergolines
NL7400790A (de) * 1973-02-02 1974-08-06
US3996228A (en) * 1973-12-21 1976-12-07 Societa' Farmaceutici Italia S.P.A. Pyrimidinoaminoethyl ergoline derivatives
US3929796A (en) * 1974-08-02 1975-12-30 Lilly Co Eli Synthesis of penniclavine and elymoclavine
US4199579A (en) * 1975-03-14 1980-04-22 Siphar S. A. Carbamates of 2-haloergolines and 2-haloergolenes and process for the preparation thereof
US4054567A (en) * 1975-08-11 1977-10-18 Eli Lilly And Company 6-Methyl-8β-hydroxymethyl-8-γ-substituted-9-ergolene compounds
US4082753A (en) * 1976-02-17 1978-04-04 Eli Lilly And Company Penniclavine acetonide
YU40004B (en) * 1977-07-21 1985-06-30 Lek Tovarna Farmacevtskih Praocess for preparing n-substituted esters of 9,10-dihydrlysergic acid
IT1094965B (it) * 1978-04-05 1985-08-10 Corvi Mora E Procedimento di preparazione di derivati del lisergolo
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity
IT1173489B (it) * 1984-03-27 1987-06-24 Inverni Della Beffa Spa Procedimento di preparazione di 1-metil-10alfa-metossilumilisergolo e di suci esteri,e intermedi per la loro preparazione
IT1213206B (it) * 1984-08-07 1989-12-14 Inverni Della Beffa Spa Procedimento per la preparazione di derivati del lisergolo.
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
FR2584720B1 (fr) * 1985-07-11 1987-10-02 Rhone Poulenc Sante Procede de preparation de derives n-methyles de l'ergoline
FR2584721B1 (fr) * 1985-07-11 1987-10-02 Rhone Poulenc Sante Procede de preparation des derives n-methyles du dihydrolysergate de methyle ou du methoxylumilysergate de methyle
FR2584719B1 (fr) * 1985-07-11 1987-10-02 Rhone Poulenc Sante Procede de preparation des derives n-methyles du lysergol et du methoxy-10a lumilysergol
US4713385A (en) * 1985-10-01 1987-12-15 Eli Lilly And Company Alkoxy and dialkoxyalkyl esters of dihydrolysergic acid and related compounds useful as 5HT receptor antagonists
US4683237A (en) * 1985-12-20 1987-07-28 Eli Lilly And Company Fluoroalkyl esters of dihydrolysergic acid useful as 5HT2 receptor antagonists
US5211504A (en) * 1991-01-31 1993-05-18 Roger Trudel Adjustable manhole top
FR2786101B1 (fr) 1998-11-24 2002-07-05 Aventis Laboratoire Utilisation de la nicergoline dans le traitement de la spasticite
FR2786100B1 (fr) 1998-11-24 2002-03-01 Aventis Laboratoire Nouvelle application therapeutique de la nicergoline
ATE502635T1 (de) 2002-08-19 2011-04-15 Pfizer Kombinationstherapie gegen hyperproliferative erkrankungen
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN119060040A (zh) 2019-01-18 2024-12-03 阿斯利康(瑞典)有限公司 Pcsk9抑制剂及其使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155667A (en) * 1964-11-03 Process for the preparation of
GB786138A (en) * 1955-02-04 1957-11-13 Sandoz Ltd New ergot alkaloid derivatives and process of making same

Also Published As

Publication number Publication date
GB981827A (en) 1965-01-27
AT258481B (de) 1967-11-27
BR6349779D0 (pt) 1973-07-03
CH446367A (de) 1967-11-15
SE315904B (de) 1969-10-13
DE1470241A1 (de) 1969-12-11
US3228943A (en) 1966-01-11
ES288887A1 (es) 1963-12-16

Similar Documents

Publication Publication Date Title
DK103780C (da) Fremgangsmåde til fremstilling af lumilysergolderivater.
DK117953B (da) Analogifremgangsmåde til fremstilling af p-aminoalkoxyphenylalkenderivater.
DK115403B (da) Fremgangsmåde til fremstilling af (3-amino-pyrazinoyl)-guanidiner.
DK104675C (da) Fremgangsmåde til fremstilling af 3-hydroxy-N-nitro-picolinamid.
DK115325B (da) Fremgangsmåde til fremstilling af fenylalkylsulfamider.
DK103476C (da) Fremgangsmåde til fremstilling af 2-oxa-3-oxo-steroider.
DK103512C (da) Fremgangsmåde til fremstilling af 3-nitroso-2-oxazolidon.
DK108915C (da) Fremgangsmåde til fremstilling af 21-acyloxy-acetyloxy-corticosteroider.
DK105161C (da) Fremgangsmåde til fremstilling af 3α-phenylgranatanderivater.
DK102746C (da) Fremgangsmåde til fremstilling af 3β-fenylgranatanderivater.
DK102920C (da) Fremgangsmåde til fremstilling af 1-cyancolchicinderivater.
DK104680C (da) Fremgangsmåde til fremstilling af derivater af 6-methyl-8-aminomethyl-ergolin I.
DK104065C (da) Fremgangsmåde til fremstilling af 3-phenylgranaten-(2)-derivater.
DK104063C (da) Fremgangsmåde til fremstilling af 4-hydroxy-5-halogenpyrimidiner.
DK115620B (da) Fremgangsmåde til fremstilling af 17α-klorætynyl-17βalkoksysteroider.
DK113647B (da) Fremgangsmåde til fremstilling af 2-sulfanilamido-5-metoxypyrimidin.
DK104941C (da) Fremgangsmåde til fremstilling af 1-hydroxymethylthiocolchicinderivater.
DK104413C (da) Fremgangsmåde til fremstilling af 1-hydroxymethylcolchicinderivater.
DK104105C (da) Fremgangsmåde til fremstilling af 2-alkoxycycloheptimidazol-derivater.
DK105532C (da) Fremgangsmåde til fremstilling af 1-hydroxymethyl-14-aminocolchicinderivater.
DK105766C (da) Fremgangsmåde til fremstilling af 1-hydroxymethyldesacetylaminothiocolchicinderivater.
DK115555B (da) Fremgangsmåde til fremstilling af nitrofurfurylidenderivater.
DK103940C (da) Fremgangsmåde til fremstilling af 16β-metylprednison-21-acetat.
DK104621C (da) Fremgangsmåde til fremstilling af monooxymethylcyclooctan.
DK103833C (da) Fremgangsmåde til fremstilling af desacetylamino-N-methylcolchiceinamid.